| Financial Year |
March 31 2023 |
| Monetary Funds |
1,240,659,618.66 |
| Held-for-trading Financial Assets |
900,000,000.00 |
| Notes Receivable |
14,126,609.81 |
| Accounts Receivable |
82,528,863.38 |
| Advances to Suppliers |
263,327,403.19 |
| Other Receivables |
7,342,665.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
460,082,823.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,620,289.49 |
| Total Current Assets |
3,027,523,383.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
73,935,408.52 |
| Investment Properties |
22,787,866.20 |
| Fixed Assetes |
1,623,373,927.58 |
| Under-construction Projects |
252,677,955.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
184,496,258.61 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
25,058,893.69 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,234,940,929.44 |
| Total Assets |
5,262,464,312.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
100,000.00 |
| Accounts Payable |
140,924,133.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,472,788.11 |
| Taxes Payable |
84,955,299.32 |
| Interest Payable |
16,999.99 |
| Dividend Payable |
1,317,692.50 |
| Other payables |
44,781,478.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,000,000.00 |
| Other Current Liabilities |
20,132,998.14 |
| Sub-Total of Current Liabilities |
601,066,677.78 |
| Long-term Loans |
161,681,855.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
358,092.70 |
| Deferred Income Tax Liabilities |
2,643,205.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
180,474,523.10 |
| Total Liabilities |
781,541,200.88 |
| Paid-In Capital(Or Share Stock) |
585,723,752.00 |
| Capital Surplus |
614,889,566.97 |
| Surplus Reserve |
413,135,033.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,475,354,686.57 |
| Minority Stockholder's Interest |
316,818,870.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,164,104,240.84 |
| Owner's Equity（Stockholder's Equity） |
4,480,923,111.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,262,464,312.57 |
